Neurofibromatosis 1 (NF1), formerly called von Recklinghausen or peripheral neurofibromatosis, and neurofibromatosis 2 (NF2), formerly called central neurofibromatosis or bilateral acoustic neurofibromatosis, are distinct autosomal dominant disorders with well defined clinical findings. As established by the NIH consensus development conference' the diagnostic criteria for NFl are met in an individual with at least two of the following (1) six or more cafe au lait macules, (2) two or more neurofibromas of any type or one plexiform neurofibroma, (3) freckling in the axillary or inguinal regions, (4) optic glioma, (5) two or more Lisch nodules, (6) a distinctive osseous lesion, (7) a first degree relative with NF1. The diagnostic criteria for NF2 include: (1) bilateral eighth nerve masses or (2) a first degree relative with NF2 and either a unilateral eighth nerve mass or two of the following: neurofibroma, meningioma, glioma, schwannoma, posterior subcapsular lens opacity.
NF2 is less common than NF1. The most recent estimation of its prevalence is about 1:250000. The gene has been assigned to the long arm of chromosome 22.2 About 50% of the cases have no family history and appear to result from a new germline mutation.
The association of lens opacities in patients with NF2 was first noted in 1986.3 As a result'of this observation, a prospective study of 47 individuals from 11 families was undertaken and the association with posterior subcapsular/capsular (PSC) opacities (the terminology used reflects the fact that these opacities were either immediately anterior to or physically continuous with the posterior lens capsule) was found to be present in 17 Three of the subjects who had NF2 and no PSC cataract had peripheral cortical lens opacities resulting in an 86-7% frequency of PSC cataract and/or cortical cataract in NF2. Therefore the data were analysed for the association of the summary marker (PSCC/CC) with NF2. Table 3 demonstrates a highly significant (p<0-0001) association between NF2 and this marker. The lower limit of the 95% confidence interval for the odds ratio of PSCC/CC and NF2 was 23-7. The odds ratio adjusted for age group (Table 3) and the odds ratio adjusted for age as a continuous variable (not shown) were similar. tAge-adjusted x2 (1 df)=49-6, p<OOOOl, the lower limit of the 95% confidence interval for the odds ratio adjusted for age group is 16-8.
The age of the patients with NF2, at the time the diagnosis of cataract was made in this study, ranged from 12 to 70 years (mean age 35-2 years) for PSC cataracts and from 12 to 66 years (mean age 36-8 years) for cortical cataracts; the distribution by age group is shown in Figure 3 . Three of these patients, however, had a history of lens opacities (cortical in two cases and PSC in one case) present from early childhood. The two at risk unaffected individuals with PSC cataract were 22 and 46 years old.
Among the 24 patients with NF2 for whom follow up data were available, progression of the lens opacities was noticed in four (two PSC, two cortical) (Fig 4) . In addition, three affected individuals developed PSC cataracts during the follow up period at ages 23, 38, and 45 years.
Discussion
The diagnostic value of lens opacities centrally located immediately anterior or juxtaposed to the posterior capsule (as documented by Scheimpflug photography) in NF2 has been reported in a prospective study in which 85% of 20 patients with NF2 had PSC lens opacities.4 The study was expanded to include more than twice the number of patients and the association was reaffirmed. The terminology recommended by the editor in the previous article4 for these opacities (based on the morphological appearance and the sensitivity in screening members of families with NF2. It is likely that most of the lens opacities were of early onset but the exact age is difficult to assess. In the present study the mean age was 35-2 and 36-8 years at the time ofthe diagnosis of PSC and peripheral cortical cataract respectively. Three of the patients were noted to have had a cataract since early childhood. On the other hand PSC opacities developed during the follow up period in three patients at ages 23-45 years.
This report suggests that peripheral cortical cataracts of early onset should be included, in addition to PSC cataracts, in the diagnostic criteria of NF2. Because of the size and location of the opacities a careful examination after maximum dilatation is required in all individuals suspected to have or at risk for NF2.
